These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cheng L, Shan A, Cheville JC, Qian J, Bostwick DG. Cancer Res; 1998 Feb 01; 58(3):389-91. PubMed ID: 9458077 [Abstract] [Full Text] [Related]
3. Differential chromosome allelic imbalance in the progression of human prostate cancer. Latil A, Fournier G, Cussenot O, Lidereau R. J Urol; 1996 Dec 01; 156(6):2079-83. PubMed ID: 8911394 [Abstract] [Full Text] [Related]
4. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs. Gradowski JF, Mantha GS, Hunt JL, Dacic S. Diagn Mol Pathol; 2007 Jun 01; 16(2):87-90. PubMed ID: 17525677 [Abstract] [Full Text] [Related]
5. Cytogenetic changes and loss of heterozygosity in atypical adenomatous hyperplasia, in carcinoma of the prostate and in non-neoplastic prostate tissue using comparative genomic hybridization and multiplex-PCR. Bettendorf O, Schmidt H, Eltze E, Gockel I, Semjonow A, Bürger H, Böcker W, Brandt B. Int J Oncol; 2005 Jan 01; 26(1):267-74. PubMed ID: 15586249 [Abstract] [Full Text] [Related]
6. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer. Jenkins R, Takahashi S, DeLacey K, Bergstralh E, Lieber M. Genes Chromosomes Cancer; 1998 Feb 01; 21(2):131-43. PubMed ID: 9491325 [Abstract] [Full Text] [Related]
7. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens. Qian J, Bostwick DG. Pathol Res Pract; 1995 Sep 01; 191(9):860-7. PubMed ID: 8606866 [Abstract] [Full Text] [Related]
8. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma. Helpap B, Riede C. Pathol Res Pract; 1995 Jun 01; 191(5):381-90. PubMed ID: 7479355 [Abstract] [Full Text] [Related]
11. Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast. Selim AG, Ryan A, El-Ayat GA, Wells CA. Cancer Detect Prev; 2001 Jun 01; 25(3):262-7. PubMed ID: 11425268 [Abstract] [Full Text] [Related]
13. Allelic imbalance in hereditary and sporadic prostate cancer. Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA, Schalken JA. Prostate; 2003 Jan 01; 54(1):50-7. PubMed ID: 12481255 [Abstract] [Full Text] [Related]
14. Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization. Qian J, Jenkins RB, Bostwick DG. Urology; 1995 Dec 01; 46(6):837-42. PubMed ID: 7502426 [Abstract] [Full Text] [Related]
16. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate. Botticelli AR. Pathologica; 1994 Apr 01; 86(2):128-41. PubMed ID: 7524011 [Abstract] [Full Text] [Related]
18. Atypical adenomatous hyperplasia of prostate lacks TMPRSS2-ERG gene fusion. Cheng L, Davidson DD, Maclennan GT, Lopez-Beltran A, Montironi R, Wang M, Tan PH, Baldridge LA, Zhang S. Am J Surg Pathol; 2013 Oct 01; 37(10):1550-4. PubMed ID: 23887154 [Abstract] [Full Text] [Related]
19. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer. Kawana Y, Ichikawa T, Suzuki H, Ueda T, Komiya A, Ichikawa Y, Furuya Y, Akakura K, Igarashi T, Ito H. Prostate; 2002 Sep 15; 53(1):60-4. PubMed ID: 12210480 [Abstract] [Full Text] [Related]